Niklas Hammar

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

Björn Wettermark, Niklas Hammar, C. MichaelFored et al. · Pharmacoepidemiology and Drug Safety · 2006 · 1.8K citations · Full text

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu et al. · Circulation · 2017 · 791 citations · Full text

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

Leif Friberg, Niklas Hammar, Mårten Rosenqvist · European Heart Journal · 2009 · 372 citations

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

Ingar Holme, Are H. Aastveit, Niklas Hammar et al. · Journal of Internal Medicine · 2009 · 312 citations

High effort, low reward, and cardiovascular risk factors in employed Swedish men and women: baseline results from the WOLF Study.

Peter R. Flatt, Lars Alfredsson, Niklas Hammar et al. · Journal of Epidemiology & Community Health · 1998 · 266 citations · Full text